In a mouse model of obesity and T2DM, CoQ10 supplementation improved lipid metabolism and mitigated obesity, possibly through CaMKII-mediated phosphodiesterase-4 inhibition [142]. The gene discussed is CAMK2G; the disease is obesity due to melanocortin 4 receptor deficiency.